Medical Oncologists' First-Line Treatment Preferences In Metastatic Urothelial Carcinoma

Andrea B. Apolo,M. Janelle Cambron-Mellott,Kathleen Beusterien,Brian S. Seal,Martine C. Maculaitis,Andrew Bernstein, Megan Epperson, Mara Lisa Jeffress,Yunes Doleh

JOURNAL OF CLINICAL ONCOLOGY（2020）

引用 1|浏览4

暂无评分

摘要

449Background: Immunotherapy and combination platinum chemotherapy are effective treatment options with different adverse events (AEs) for patients (pts) with metastatic urothelial carcinoma (mUC)....

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要